CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Est. Return
21.68%
1 Year Est. Return
+21.68%
AUM
$16B
AUM Growth
-$1.4B
(-8.1%)
Holding
734
Top Buys
| 1 | +$108M | |
| 2 | +$77.8M | |
| 3 | +$52.5M | |
| 4 |
Intuitive Surgical
ISRG
|
+$50.7M |
| 5 |
Agilent Technologies
A
|
+$34.9M |
Top Sells
| 1 | +$67M | |
| 2 | +$45.8M | |
| 3 | +$42.2M | |
| 4 |
Becton Dickinson
BDX
|
+$36M |
| 5 |
Eli Lilly
LLY
|
+$35.8M |
Sector Composition
| 1 | Technology | 31.51% |
| 2 | Healthcare | 25.4% |
| 3 | Financials | 11.6% |
| 4 | Consumer Discretionary | 7.99% |
| 5 | Industrials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Costco
COST
$417B
| $53.3M | 0.33% |
56,353
-2,100
|
|
||
77
Marvell Technology
MRVL
$75.5B
| $53.3M | 0.33% |
865,407
+10,039
|
|
||
78
Xylem
XYL
$36.4B
| $52.6M | 0.33% |
440,711
-227,973
|
|
||
79
Incyte
INCY
$20.2B
| $52.6M | 0.33% |
868,545
-166,107
|
|
||
80
Rockwell Automation
ROK
$40.5B
| $51.9M | 0.32% |
200,774
-5,689
|
|
||
81
Applied Materials
AMAT
$183B
| $50.8M | 0.32% |
349,841
-100,463
|
|
||
82
Netflix
NFLX
$463B
| $50.1M | 0.31% |
53,704
-3,122
|
|
||
83
Johnson & Johnson
JNJ
$450B
| $49.6M | 0.31% |
299,114
+22,060
|
|
||
84
Quest Diagnostics
DGX
$19.8B
| $47.1M | 0.3% |
278,656
+110,946
|
|
||
85
Fiserv
FI
$34.7B
| $46.6M | 0.29% |
211,206
+5,247
|
|
||
86
Otis Worldwide
OTIS
$35.3B
| $46.5M | 0.29% |
450,128
-50,952
|
|
||
87
Monolithic Power Systems
MPWR
$45.9B
| $44.5M | 0.28% |
76,651
+25,859
|
|
||
88
Allstate
ALL
$51.5B
| $43.2M | 0.27% |
208,509
+99,471
|
|
||
89
BioMarin Pharmaceuticals
BMRN
$10.1B
| $43M | 0.27% |
607,862
+27,640
|
|
||
90
PNC Financial Services
PNC
$71.7B
| $42.9M | 0.27% |
243,980
+2,388
|
|
||
91
Boston Scientific
BSX
$147B
| $42.1M | 0.26% |
414,812
+23,054
|
|
||
92
Pfizer
PFE
$191B
| $42.1M | 0.26% |
1,659,600
+1,237,099
|
|
||
93
Waste Connections
WCN
$43.2B
| $40.1M | 0.25% |
205,685
-108,894
|
|
||
94
Exxon Mobil
XOM
$481B
| $39.5M | 0.25% |
332,097
-1,164
|
|
||
95
Ascendis Pharma
ASND
$12.6B
| $37.8M | 0.24% |
242,761
-37,393
|
|
||
96
Neurocrine Biosciences
NBIX
$14.3B
| $36.6M | 0.23% |
330,840
+26,868
|
|
||
97
Parker-Hannifin
PH
$97.3B
| $36.3M | 0.23% |
59,701
+355
|
|
||
98
Coca-Cola
KO
$295B
| $35.7M | 0.22% |
498,338
+13,335
|
|
||
99
Mettler-Toledo International
MTD
$29.3B
| $35.4M | 0.22% |
29,948
+16,584
|
|
||
100
T-Mobile US
TMUS
$231B
| $34.7M | 0.22% |
130,266
+57,033
|
|